Methods of use of phenanthridium DNA intercalators for fluorescence detection
AssigneeAbbott Laboratories
InventorsChristopher Bieniarz, Jeffrey B. Huff, Denis R. Henrard
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsChristopher Bieniarz, Jeffrey B. Huff, Denis R. Henrard
Estimating the term…
Phenanthridium compounds are provided which are comprised of intercalators and substituted intercalator segments having a functionalized chain or chains which provide a high affinity for binding to the DNA molecule and show reduced self-quenching, while providing superior transport kinetics. The compounds have been found to provide enhanced fluorescence when bound to a DNA molecule within a fluorescent flow cytometry environment which is about eight to ten times brighter in fluorescence than "bis" structure intercalators and other known intercalators utilized in flow cytometry environment, said enhancement of fluorescence allows a drastic reduction in the amount of intercalator needed for applications of similar sensitivity than those using known intercalators. Substantial improvements in material use efficiency, accuracy and dependability of various DNA studies are direct results of the inventive intercalator compounds, said compounds having use in known DNA intercalator applications inclusive of flow cytometry, gel electrophoresis, DNA detection, immunoassay for DNA, fluorescence in situ hybridization assays, DNA sequencing application, therapeutic application and conversion staining methodologies.
A method for detecting a target nucleic acid in a sample, said method comprising:
A method of separating a nucleic acid from a sample comprising:
A method for determining one or more characteristics of cells using a fluorescence analysis comprising:
Dependencies are inferred from the claim text.